

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Fleroxacin is a broad-spectrum antimicrobial fluoroquinolone. |
| Concentration | Treated Time | Description | References | |
| HEK293-hOCT3 cells | 1 mM | 15 minutes | Evaluate the inhibitory effect of Fleroxacin on hOCT3-mediated MPP+ uptake, results showed Fleroxacin did not significantly inhibit hOCT3-mediated MPP+ uptake but apparent stimulation was observed | Antimicrob Agents Chemother. 2013 Jun;57(6):2705-11 |
| HEK293-hOCT2 cells | 1 mM | 15 minutes | Evaluate the inhibitory effect of Fleroxacin on hOCT2-mediated TEA uptake, results showed Fleroxacin did not significantly inhibit hOCT2-mediated TEA uptake | Antimicrob Agents Chemother. 2013 Jun;57(6):2705-11 |
| HEK293-hOCT1 cells | 1 mM | 15 minutes | Evaluate the inhibitory effect of Fleroxacin on hOCT1-mediated TEA uptake, results showed Fleroxacin significantly inhibited hOCT1-mediated TEA uptake (∼20% inhibition) | Antimicrob Agents Chemother. 2013 Jun;57(6):2705-11 |
| gyrA mutant Staphylococcus aureus | 0.5 μg/ml | 14 hours | Determine the minimum inhibitory concentration (MIC) of Fleroxacin against gyrA mutant Staphylococcus aureus | Antimicrob Agents Chemother. 2001 Dec;45(12):3544-7 |
| grlA mutant Staphylococcus aureus | 4 μg/ml | 14 hours | Determine the minimum inhibitory concentration (MIC) of Fleroxacin against grlA mutant Staphylococcus aureus | Antimicrob Agents Chemother. 2001 Dec;45(12):3544-7 |
| Wild-type Staphylococcus aureus MS5935 | 0.5 μg/ml | 14 hours | Determine the minimum inhibitory concentration (MIC) of Fleroxacin against wild-type Staphylococcus aureus MS5935 | Antimicrob Agents Chemother. 2001 Dec;45(12):3544-7 |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT03600480 | Obesity Overw... 展开 >>eight 收起 << | Phase 1 | Recruiting | January 22, 2020 | United States, Kansas ... 展开 >> Novo Nordisk Investigational Site Recruiting Overland Park, Kansas, United States, 66212 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.71mL 0.54mL 0.27mL |
13.54mL 2.71mL 1.35mL |
27.08mL 5.42mL 2.71mL |
|
| CAS号 | 79660-72-3 |
| 分子式 | C17H18F3N3O3 |
| 分子量 | 369.34 |
| SMILES Code | O=C(C1=CN(CCF)C2=C(C=C(F)C(N3CCN(C)CC3)=C2F)C1=O)O |
| MDL No. | MFCD00864880 |
| 别名 | RO 23-6240; AM-833; Fleroxacin, Quinodis, Megalocin, AM-833, Ro 236240 |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, room temperature |
| 溶解方案 |
H2O: 30 mg/mL(81.23 mM),配合低频超声,并调节pH至11 0.1 M NaOH: 8 mg/mL(21.66 mM),配合低频超声,并调节pH至11 |
沪公网安备 31011702889066号
沪ICP备2024050318号-1